Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Treatment and prophylaxis of infection in severe burns Age: Adult |
Dose: Topical/Cutaneous – Apply onto affected area Frequency: 1-2 times daily |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Burn Wound Infections (2°/3°) Age: less than 2 months |
Dose: Cream – 1% Note: Contraindicated |
|
Indication: Burn Wound Infections (2°/3°) Age: greater than 2 months |
Dose: Cream – 1% Frequency: Apply onto affected area 1-2 times/day. |
Administration
- Clean wound before applying
- Apply thin layer to affected area
Side Effect
- burning
- itching and rashes
- argyria reported following prolonged use
- Transient leucopenia may occur in patients receiving silver sulfadiazine therapy
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Sulphonylureas
|
Potentiates antidiabetic effect
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Pregnancy at Term
|
Risk of kernicterus in newborn
|
|
Hepatic/Renal Impairment
|
Cannot be properly processed
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.